19 Park City Kids Get Whooping Cough. All 19 Were Vaccinated.

Preacher

Gold Member
Jan 29, 2015
29,660
5,948
290
Georgia Mountains
19 Park City Kids Get Whooping Cough. All 19 Were Vaccinated. The Edgy Truth

vaccine doesn't work but lets look at the side effects of this vaccine
Whooping Cough Vaccine Risks You Should Know
According to Barbara Loe Fisherv,

"Of all the vaccines which have been routinely used by children in the past century, the brain damaging effects of the pertussis (whooping cough) portion of DPT vaccine is among the most well documented in the scientific literature.

Created in 1912, the crude pertussis vaccine basically consisted of B. pertussis bacteria killed with heat, preserved with formaldehyde, and injected into children. In the early 1940's, aluminum was added as an adjuvant and later the mercury preservative, thimerosal, was added when pertussis was combined with diphtheria and tetanus vaccines to create DPT. Pertussis vaccine was never studied in large clinical trials before being given to children in the first half of the 20th century or after it was combined into DPT and recommended for mass use by the American Academy of Pediatrics in 1947."

Children who are particularly high-risk for brain injury or death after getting a pertussis-containing vaccine (DTaP or Tdap) include those who have suffered previous vaccine reactions, such as:

  • High fever
  • High pitched screaming or persistent crying
  • Convulsions (with or without fever)
  • Collapse/shock (also known as hypo-tonic/hypo-responsive episodes)
  • Brain Inflammation and encephalopathy
Most of the adverse effects are believed to occur from the effects of the pertussis toxin itself, which is one of the most lethal toxins in nature. It's a well-known neurotoxin that is so reliable for inducing brain inflammation and brain damage that it's used to deliberately induce experimental autoimmune encephalomyelitis (EAE) in lab animals. The toxin is implicated in brain inflammation caused both by the disease (whooping cough) itself, and complications from pertussis-containing vaccines.

For more in-depth information on the DPT vaccine, I highly recommend reading Barbara Loe Fisher's book DPT: A Shot in the Dark, which was the first major, well documented critique of America's mass vaccination system calling for safety reforms and the right to informed consent to vaccination.


Oh lovely!
 
Don't ya just hate it when a kid's got the whooping cough?...

Scientists develop potential treatment for whooping cough
Dec. 3, 2015 - Two new antibodies prevented or eliminated pertussis infection in mice and baboons.
Scientists at the University of Texas have developed two antibodies that could reduce the occurrence and threat of pertussis, which is a major cause of infant death in developing countries and has been increasing in the United States in the last 20 years. Pertussis, or whooping cough, a respiratory tract infection that damages the immune system can causes the white blood cell count to rise to levels that can blood blood flow through the lungs.

Childhood vaccination generally prevents the disease in the United States, although as more parents have delayed or decided against vaccinations, whooping cough cases have increased during the last 20 years. "Most of the babies who get sick haven't been immunized, so we hope to provide the immunity that they are lacking," said Jennifer Maynard, a chemical engineer in the Cockrell School of Engineering at the University of Texas, in a press release.

Scientists-develop-potential-treatment-for-whooping-cough.jpg

A treatment for whooping cough could prevent illness or death in children who are either too young for vaccination or whose parents have decided against it.​

Based on the idea that lowering white blood cell counts in patients is key to defeating the infection, scientists developed two antibodies that can be used either together or separately -- one antibody binds to the pertussis toxin and prevents it from attaching to healthy cells and the second prevents the toxin from reaching its target inside a healthy cell it has invaded. In tests with mice who were not infected with pertussis, the antibodies acted like a vaccine and prevented infection.

When the antibodies were given to baboons who were infected, the animals' white blood cell counts decreased and symptoms slowed or stopped. When combined with antibiotics, the scientists said the antibodies could kill the bacteria that causes pertussis. "In the developing world, an estimated 200,000 babies die a year, and that's where we think we can have a really big impact," Maynard said. "If we can get our antibodies to these high-risk infants, we could potentially prevent the infection from occurring in the first place." The study is published in Science Translational Medicine.

Scientists develop potential treatment for whooping cough
 
Whooping cough booster shot fades fast...

Whooping cough protection fades fast after booster shot
Feb. 8, 2016 - Researchers suggest giving the shot every three or four years could better maintain its efficacy.
Protection against whooping cough provided by a vaccine booster shot drops significantly after two years, and to less than 10 percent after four years, according to a recent study. Kaiser Permanente researchers said the Tdap booster showed decreasing efficacy in the years after it was given to teenagers who have only received newer versions of the five-part DTaP vaccine that prevents whooping cough, tetanus and diphtheria. The current DTaP vaccine came into use during the 1990s, replacing the DTwP that had been used since the 1950s. The newer vaccine uses proteins from the pertussis bacteria, instead of whole inactivated cells, in order to bypass side effects of the original version. Outbreaks of whooping cough in recent years have been blamed not only on incomplete rounds of vaccination, but also on its efficacy waning over time.

Whooping-cough-protection-fades-fast-after-booster-shot.jpg

The Tdap booster shot has been given to 11- and 12-year-olds since 2006 since to increase protection against pertussis, tetanus, and diptheria because vaccines have been found to wane in their efficacy over time.​

DTaP is given to children at 2, 4, and 6 months of age, with booster shots between 15 and 18 months old and between 4 and 6 years old, for full protection against the diseases. Tdap is recommended as an additional booster for children between age 11 and 12 "The strategy of routinely vaccinating adolescents to prevent future disease did not prevent the 2014 epidemic, arguably because the protection afforded by a dose of Tdap was too short-lived," Dr. Nicola Klein, co-director of the Kaiser Permanente Vaccine Study Center, said in a press release. "While awaiting development of new vaccines that will provide longer-lasting protection against pertussis, we should consider alternate Tdap immunization strategies for adolescents." For the study, published in the journal Pediatrics, researchers analyzed 1,207 pertussis cases among adolescent members of Kaiser Permanente Northern California's managed care who were vaccinated with DTaP vaccine between 2010 and 2014.

Researchers found the booster protected 69 percent of teens against whooping cough, which dropped to 57 percent adolescents in the second year, 25 percent in the third year, and about 9 percent in the fourth year. Klein said the study suggests shifting the schedule of vaccines for Tdap, possibly giving it every three or four years at all ages, as a way to better prevent infection. "It provides moderate protection during the first year but years two and three after vaccination, there is not that much protection left," Klein told CNN. "The idea of giving the booster to 11- and 12-year-olds -- the recommendation, and in California, the requirement -- is to prevent infections and outbreaks, and that is unfortunately not what we found."

Whooping cough protection fades fast after booster shot
 

Forum List

Back
Top